Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gastrointestinal Cancers
•
Gastroenterology
•
General Hepatology
How would you approach the workup of a patient with a history of HCC post-TARE with a recent non-viable MRI but a new portal vein thrombosis?
Related Questions
What is your approach to liver transplantation candidacy in those with decompensated cirrhosis who have been treated for a solid-organ malignancy, such as oral SCC?
Based on the recent 2025 "Consensus Recommendations by the US Multi-Society Task Force on Colorectal Cancer", how have you incorporated split prep, simplified preprocedural diet, and use of simethicone into your practice?
When would you consider use of EUS guided liver biopsy over percutaneous and/or transjugular?
How do you determine whether to limit volume removal during therapeutic paracentesis in a patient without acute or chronic kidney disease?
Do you avoid peritoneal dialysis in cirrhotic patients with ascites?
Which GI cancer patients do you use oral contrast in staging CT scans?
Is there a serum ammonium level for which you recommend initiation of dialysis in a patient with hepatic encephalopathy?
How long do you recommend waiting after variceal bleeding and banding before a transesophageal echocardiogram can be performed safely?
When giving albumin challenge, for acute kidney injury with suspected hepatorenal syndrome, do you administer a single dose daily or split the dose of albumin?
How do you approach dosing beta blockers for variceal prophylaxis when the standard dose doesn’t achieve the target heart rate?"
